Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
19 sept. 2024 08h31 HE
|
Neuronetics
MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Releases Software Upgrades to Elevate Patient Care
16 sept. 2024 08h32 HE
|
Neuronetics
MALVERN, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories
03 sept. 2024 08h29 HE
|
Neuronetics
MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
20 août 2024 08h29 HE
|
Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
12 août 2024 07h15 HE
|
Neuronetics
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they have...
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results
12 août 2024 07h10 HE
|
Neuronetics
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 août 2024 16h36 HE
|
Neuronetics
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
01 août 2024 08h29 HE
|
Neuronetics
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
31 juil. 2024 08h30 HE
|
Neuronetics
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
30 juil. 2024 08h30 HE
|
Neuronetics
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...